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• Apoptosis by TUNEL assay 
TUNEL  (TdT  mediated  dUTP  Nick  End  Labelling) 
staining  was performed to  estimate  the  percentage of 
apoptotic cells of 5-FU alone and 5-FU in combination 
with Q or L,  as well  as,  z-VAD-fmk (zVAD) alone and 
zVAD in combination with Q, L and staurosporine (STS). 
Cells were collected, fixed and cytospined to a polylysine 
treated slide. Then, cells were permeabilised with 0.1% 
Triton X-100 in  0.1% sodium citrate  for  2  min on ice. 
TUNEL  assay  was  performed  following  the 
manufacture’s  instructions (Roche).  The percentage of 
apoptotic  cells  was  calculated  from the  ratio  between 
TUNEL positive cells  and total  number of  cells  (nuclei 
staining with Hoechst) using a fluorescent microscope.   
• Apoptosis-related-Protein Expression by Western Blotting  
The  abundance  of  p53  (DO-1),  cleaved  caspase-9  (Asp  315), 
caspase-3  (H-277),  PARP-1  (F-2),  Bcl-2  (C21)  and  -actin  were 
measured  by  western  blot.  After  24h  of  treatment  with  test 
compounds,  cells  were  lysed  and  then  separated  by  SDS  gel 
electrophoresis  and  electroblotted  to  a  PVDF  membrane. 
Membranes were blocked and incubated with primary antibody and 
secondary antibody. Immunoreactive bands were detected using the 
Immobilon solutions under a chemiluminescence detection system. 
-actin was used as a loading control.  
Fig. 1 - Effect on apoptosis by 5-fluorouracil (FU) 500, 100 and 1M, quercetin 12M (Q12) and luteolin 12M (L12) alone, as well as the 
natural compounds co-incubated with FU for 48h, in HCT15 (A) and CO115 (B) cells, using TUNEL assay. Results are presented as mean 
± SEM of at least 3 independent experiments. *** P 0.001, when compared with control; ++ P 0.01, when compared with the respective 
natural compound alone; ## P 0.01 and ### P 0.001, when compared with FU alone; NS, not significant differences observed between 
each other.  
 Introduction 
Colorectal tumors (CRC) with microsatellite instability (MSI) and mutations in p53 show resistance to chemotherapy with 5-fluorouracil  (5-FU), the most widely 
pharmacological  drug  used  for  CRC treatment.  In  a  previous  study,  we showed that  two  flavonoids  quercetin  (Q)  and  luteolin  (L)  have  antiproliferative  and 
proapoptotic effects on two human MSI CRC derived cell lines: CO115 (wild-type for p53) and HCT15 (harbors a p53 mutation). The present study aims to find if the 
combination of Q or L with 5-FU increases sensitivity of CRC cells to 5-FU and characterize the dependence of the compounds on the p53 status. The sensitivity of 
the cells to 5-FU was evaluated by TUNEL assay and the effects on apoptosis induction of co-incubation of the flavonoids, quercetin (Q) or luteolin (L), with 5-FU 
were characterized. The mechanisms of apoptosis induction were assessed by western blot, and p53 mediated effects confirmed by small interference RNA (siRNA) 
in CO115 cells and using HCT116 wild-type and p53 knockout cells. This study suggests the potential applicability of these phytochemicals for enhancement of 5-FU 
efficiency in CRC therapy, especially Q in p53 wild-type tumors. 
Fig. 2 - Effect of a caspase inhibitor zVAD-FMK (zVAD) 20M on the apoptosis induction by quercetin 12M (Q12), 
luteolin 12M (L12) and staurosporine (STS) 0.25M, for 48h, in HCT15 (A) and CO115 (B) cells, using TUNEL assay. 
Results are presented as mean ± SEM of at least 3 independent experiments. * P 0.05, *** P 0.001, when compared 
to control; ++ P 0.01 and +++ P 0.001, when compared with the respective compound alone; ## P 0.01 and ### P 
0.001, when compared with zVAD alone; NS, not significant differences observed between each other. Effects on 
caspase-9, caspase-3 and PARP-1 expressions, for 48h, of Q, L, 5-FU (FU) and STS alone, in HCT15 and CO115 
cells (C), by western blot. Images are representative of at least 3 independent experiments. 
Fig. 3 - Effects on caspase-9, 
caspase-3,  PARP-1,  p53  and  
Bcl-2  expressions,  for  48h,  of 
co-incubation  of  quercetin 
12M (Q12) and 5-fluorouracil 
1M (FU1) in CO115 cells, by 
western  blot.  Images  are 
representative  of  at  least  3 
independent experiments. 
Fig. 4 – Dependence on p53 for apoptosis induction by quercetin (Q) and 5-fluorouracil (FU). (A) CO115 cells knockdown for p53 by siRNA (100nM) were incubated with FU 
1M (FU1) or Q 12M (Q12) alone, and with both in combination for 48h and apoptosis assessed by TUNEL assay. Control cells were transfected with control siRNA. 
Compounds were added 24h after transfection. p53 knockdown efficiency was monitored by western blot (inset). (B) HCT116 p53-wt (p53 +/+) and HCT116 p53-null (p53 -/-) 
cells were used to observe effects of FU, Q and both in combination on apoptosis after 48h of incubation, as assessed by TUNEL assay. FU10: FU 10M; FU100: FU 100M; 
Q15: Q 15M. (A; B) Results are presented as mean ± SEM of at least 3 independent experiments. * P 0.05, ** P 0.01 and *** P 0.001, when compared with control; + P 
0.05, when compared with each other; ### P 0.001, when compared with respective FU alone; Ø P 0.05, when compared with respective Q alone; NS, not significant 
differences observed between each other.  
• p53 knokdown in CO115 cells 
CO115 cells were transiently transfected with Oligofectamine 
and  100nM of  p53  siRNA in  OPTI-MEN according  to  the 
manufacturer’s instructions. The p53 siRNA target sequence 
was  guggaguauuuggaugaca  (Invitrogen).  Control  of  siRNA 
experiments were included by using a siRNA against GFP. 
Confirmation of  p53 knockdown was done by western blot 
analysis. 24h after transfection, cells were incubated with 5-
FU or Q alone and with both in combination, for 48h, and 
apoptosis measured by the TUNEL assay. 
• p53 knockout  in HCT116 cells 
Two isogenic HCT116 colon carcinoma cells, p53-wild type 
and  p53  complete  knockout  for  p53,  kindly  provided  by 
Vogelstein, were used. 
CO115 cells are more sensitive to 5-FU than the p53 mutated HCT15 
cells. Q synergistically induced apoptosis with 5-FU in CO115 cells. 
Additive effects on apoptosis were observed for L + 5-FU (in both cell 
lines) and Q + 5-FU (in HCT15). 
Apoptosis induced by Q and L was caspase dependent 
in CO115 cells but not in HCT15.  
Q remarkably increased p53 expression in CO115 cells and knockdown of p53 by 
siRNA in these cells abrogated the induction of apoptosis by Q and 5-FU (Fig. 4A).  
p53 knockout in HCT116 cells totally abrogated apoptosis induction by Q  and 5-FU (Fig. 
4B). 
Molecular  markers  of  apoptotic 
mitochondrial  pathway  were  also 
synergistically induced by Q and 5-
FU. 
Potential applicability of Q and L for 
enhancement of 5-FU efficiency  
in CRC therapy 
Q demonstrated to induce apoptosis 
dependent on p53 status 
